NasdaqCM - Nasdaq Real Time Price • USD
Achieve Life Sciences, Inc. (ACHV)
As of 9:34 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 5 |
| Avg. Estimate | -0.24 | -0.22 | -1.03 | -0.9 |
| Low Estimate | -0.31 | -0.24 | -1.38 | -1.17 |
| High Estimate | -0.16 | -0.17 | -0.85 | -0.71 |
| Year Ago EPS | -0.5 | -0.43 | -1.5 | -1.03 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.69 | -0.42 | -0.38 | -0.31 |
| EPS Actual | -0.5 | -0.43 | -0.34 | -0.26 |
| Difference | 0.19 | -0.01 | 0.04 | 0.05 |
| Surprise % | 27.50% | -2.40% | 10.50% | 16.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.22 | -1.03 | -0.9 |
| 7 Days Ago | -0.24 | -0.22 | -1.03 | -0.9 |
| 30 Days Ago | -0.29 | -0.29 | -1.24 | -0.86 |
| 60 Days Ago | -0.3 | -0.31 | -1.24 | -0.81 |
| 90 Days Ago | -0.3 | -0.31 | -1.24 | -0.81 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 2 | 2 | 5 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ACHV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 52.00% | -- | -- | 1.50% |
| Next Qtr. | 48.80% | -- | -- | 12.10% |
| Current Year | 31.30% | -- | -- | 4.40% |
| Next Year | 12.60% | -- | -- | 13.20% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | JonesTrading: Buy | 4/17/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 4/1/2024 |
| Maintains | Lake Street: Buy to Buy | 3/5/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 12/12/2023 |
| Maintains | Lake Street: Buy to Buy | 5/31/2023 |
| Maintains | Lake Street: Buy to Buy | 5/10/2023 |
Related Tickers
AKTX Akari Therapeutics, Plc
1.1900
0.00%
SLN Silence Therapeutics plc
21.40
-1.02%
LADX LadRx Corporation
2.2500
+0.90%
KRBP Kiromic BioPharma, Inc.
2.7100
0.00%
XCUR Exicure, Inc.
0.5090
-1.17%
APVO Aptevo Therapeutics Inc.
0.6800
0.00%
MBIO Mustang Bio, Inc.
0.3699
+3.47%
CALC CalciMedica, Inc.
5.33
-2.31%
FBLG FibroBiologics, Inc.
11.68
+1.39%
NGENF NervGen Pharma Corp.
1.5000
-1.96%